Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04522986

An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection — COVID-19  

Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Trial

Official title:
An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection

Clinical Trial Summary

Safety and efficacy of ADR-001 are evaluated in Patients with Severe Pneumonia caused by SARS-CoV-2 infection.

Clinical Trial Description

Patients with Severe Pneumonia caused by SARS-CoV-2 infection are enrolled to the study. Adipose-derived mesenchymal stem cells (AD-MSCs) are administered once a week, total four times intravenously. Safety and efficacy of AD-MSCs are evaluated for 12 weeks after first administer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04522986
Study type Interventional
Source Rohto Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date August 21, 2020
Completion date February 2, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05543616 - A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children Phase 2/Phase 3
Recruiting NCT04516811 - Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 Phase 3
Completed NCT04334044 - Treatment of SARS Caused by COVID-19 With Ruxolitinib Phase 1/Phase 2
Terminated NCT04371978 - Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 Phase 3
Recruiting NCT04466241 - Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial Phase 2/Phase 3
Withdrawn NCT04381923 - COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia N/A
Recruiting NCT04402879 - CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals N/A
Recruiting NCT04661631 - Surgery and Lung Ultrasound in COVID-19 Infection
Completed NCT04376476 - Host-pathogen Interactions During SARS-CoV-2 Infection N/A
Completed NCT04375098 - Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection Phase 2
Completed NCT04402060 - A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 Phase 1/Phase 2
Active, not recruiting NCT04365101 - Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 Phase 1/Phase 2
Completed NCT04354779 - Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.
Recruiting NCT04367207 - African Covid-19 Critical Care Outcomes Study
Terminated NCT04409873 - Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) Phase 2
Completed NCT04602351 - Communication in ICU During COVID-19
Terminated NCT04707703 - Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis Phase 3
Active, not recruiting NCT04987528 - Pulmonary Fibrosis During Severe COVID-19 Pneumonia
Completed NCT04667936 - Evaluation of Sedation in COVID-19 ARDS
Completed NCT04423770 - COVID-19 Related Health and Infection Control Practices Among Dentists